Market Snapshot

BSE Sensex: 79486.32 -0.07%
BSE 500: 35663.87 -0.67%
BSE 200: 11109.17 -0.53%
BSE 100: 25503.64 -0.32%
BSE MidCap: 46080.07 -1.18%
BSE SmallCap: 54913.85 -1.52%
BSE BANKEX: 58857.86 -0.65%
BSE IT: 41975.89 0.54%
Nifty 50: 24148.2 -0.21%
Nifty 500: 22645.65 -0.70%
Nifty 200: 13602.3 -0.58%
Nifty 100: 25002.95 -0.43%
Nifty Midcap 100: 56352 -1.33%
Nifty Small 100: 18445.6 -1.70%
Nifty IT: 42050.15 0.71%
Nifty PSU Bank: 6845.2 -1.97%

News:

Tata Motors Q2 PAT drops 10% Y...
Ashok Leyland gains as Q2 PAT ...
Vedanta reports turnaround Q2 ...
Bharat Electronics bags orders...
Bharat Bijlee slumps as Q2 PAT...

Vanta Bioscience Ltd Share Price – BSE
Miscellaneous, Small Cap

Invest

08 Nov 2024 | 03:59 PM

48.02

-2.52 (-4.99%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

14.33%

Return (1Y)

Underperformed BSE Sensex by 8%
More Volatile

5.62%

Standard Deviation (1Y)

Higher than BSE Sensex by 4.76%
Not so consistent

5/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

102

News & Announcements

Vanta Bioscience postpones board meeting
114 days ago

Vanta Bioscience postpones board meeting

18 - Jul - 2024 12:00 AM | 114 days ago

Vanta Bioscience has postponed the meeting of the Board of Directors which was scheduled to be held on 17 July 2024. The meeting will now be held on 19 July 2024.
Powered by Capital Market - Live News
Vanta Bioscience to table results
121 days ago

Vanta Bioscience to table results

11 - Jul - 2024 12:00 AM | 121 days ago

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 17 July 2024.
Powered by Capital Market - Live News
Vanta Bioscience wins order of Rs 1.2 cr
220 days ago

Vanta Bioscience wins order of Rs 1.2 cr

03 - Apr - 2024 12:00 AM | 220 days ago

Vanta Bioscience has received an order of Rs. 1.2 crore from a large Indian Multinational Company to carry out Technical Studies which includes oral toxicity study, Dermal Toxicity and in vitro tests and other studies. The said studies will be carried out by the Company from its state of art research facility at Gummidipundi, Chennai. The turnaround time of the Company for the project will be 5-24 weeks from receipt of requisite test items and/or such extended period as mutually agreed. Upon successful completion of the above, the Company is confident of receiving orders worth Rs. 12 crore approx. in next 2 financial years in one or more tranches from the said Company.
Powered by Capital Market - Live News
Vanta Bioscience wins order of Rs 57 lakh
343 days ago

Vanta Bioscience wins order of Rs 57 lakh

02 - Dec - 2023 12:00 AM | 343 days ago

Vanta Bioscience has received order of Rs 57 lakh from a renowned Singapore Company to carry out GLP Studies which includes Bacterial Reverse Mutation assay, oral toxicity study and in vitro tests and other studies.
The said studies will be carried out by the Company from its state of art research facility at Gummidipundi, Chennai. The turnaround time of the Company for the project will be 26 weeks from receipt of requisite test items and/or such extended period as mutually agreed
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Vanta Bioscience Ltd has opened at 48.02 i.e -4.99% below then yesterday's closing price of 50.54
Vanta Bioscience Ltd has the Lowesr P/E ratio according to FY 202403 data among stocks in Miscellaneous Sector
Vanta Bioscience Ltd has the Lowesr P/B ratio according to FY 202403 data among stocks in Miscellaneous Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Vanta Bioscience Ltd Share Price – BSE Miscellaneous, Small Cap

48.02 -2.52 (-4.99%)

News & Announcements

Price vs Volume

Stock Trivia

Vanta Bioscience Ltd Share Price – BSE
Miscellaneous, Small Cap

48.02

-2.52 (-4.99%)